Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
Two Penn Professors Named National Academy of Inventors Fellows

Two Penn Professors Named National Academy of Inventors Fellows

Professors James Eberwine, of the University of Pennsylvania’s Perelman School of Medicine and Shu Yang, of Penn’s School of Engineering and Applied Science, have been

Karen Kreeger , Evan Lerner

Penn Medicine Study: U.S. Workers Sacrifice Sleep for Work Hours and Long Commutes

Penn Medicine Study: U.S. Workers Sacrifice Sleep for Work Hours and Long Commutes

An increasing number of studies show that chronically restricted sleep to less than seven hours per day impairs performance, increases the risk for errors and accidents, and is associated with negative health consequences like obesity, diabetes, and cardiovascular disease.

Greg Richter

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent.

Karen Kreeger

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Lee-Ann Donegan

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicineresearchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.

Steve Graff

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.

Holly Auer

Penn Vet-Berkeley Study: New Therapy Holds Promise for Restoring Vision

Penn Vet-Berkeley Study: New Therapy Holds Promise for Restoring Vision

A new chemical-genetic therapy restores light responses to the retinas of blind mice and dogs and enables the mice to guide their behavior according to visual cues, setting the stage for clinical trial in humans.

Katherine Unger Baillie